Organon & Co. (OGN): Price and Financial Metrics
GET POWR RATINGS... FREE!
OGN Stock Price Chart Interactive Chart >
OGN Price/Volume Stats
Current price | $35.86 | 52-week high | $39.47 |
Prev. close | $34.92 | 52-week low | $28.42 |
Day low | $35.10 | Volume | 1,812,000 |
Day high | $36.08 | Avg. volume | 1,956,777 |
50-day MA | $34.99 | Dividend yield | 3.12% |
200-day MA | $33.87 | Market Cap | 9.10B |
Organon & Co. (OGN) Company Bio
Organon & Co. Organon & Co. is a science-based global pharmaceutical company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. Its women's health portfolio includes Nexplanon or Implanon NXT, which is a patented long-acting reversible contraceptive. Its operating segments include the Organon Products segment. The Organon Products segment is engaged in developing and delivering health solutions through its portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's products segment portfolio includes: Women's Health, Biosimilars and Established Brands. Women's Health contains contraception and fertility brands, such as Nexplanon or Implanon NXT, NuvaRing and elonva. The Company's Biosimilars portfolio consists of three immunology products: Brenzys, Renflexis and Hadlima; and two oncology products: Ontruzant and Aybintio.
Latest OGN News From Around the Web
Below are the latest news stories about Organon & Co that investors may wish to consider to help them evaluate OGN as an investment opportunity.
Organon & Co. (NYSE:OGN) Looks Interesting, And It's About To Pay A DividendRegular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Organon & Co... |
Organon declares $0.28 dividendOrganon (NYSE:OGN) declares $0.28/share quarterly dividend, in line with previous. Forward yield 3.08% Payable March 17; for shareholders of record Feb. 28; ex-div Feb. 25. See OGN Dividend Scorecard, Yield Chart, & Dividend Growth.... |
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2021JERSEY CITY, N.J., February 17, 2022--Organon reports results for the fourth quarter and full year ended December 31, 2021 |
Organon Acquires Contraceptive Products, Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong and Macau, and Agrees to Acquire these Products in VietnamJERSEY CITY, N.J., February 16, 2022--Organon Acquires Marvelon® and Mercilon®, in the People’s Republic of China, including Hong Kong, Macau, Agrees to Acquire these Products in Vietnam |
How Many Organon & Co. (NYSE:OGN) Shares Do Institutions Own?A look at the shareholders of Organon & Co. ( NYSE:OGN ) can tell us which group is most powerful. Large companies... |
OGN Price Returns
1-mo | -7.81% |
3-mo | 2.36% |
6-mo | 22.18% |
1-year | 22.77% |
3-year | N/A |
5-year | N/A |
YTD | 19.66% |
2021 | N/A |
2020 | N/A |
2019 | N/A |
2018 | N/A |
2017 | N/A |
OGN Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Loading social stream, please wait...